Esperion Therapeutics, Inc. (ESPR) Loss Submission Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Submit Transaction Detail Now (Optional)

- OR -

    This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

    FAX: 212-363-7171

    The complaint alleges that Esperion Therapeutics, Inc. violated federal securities laws by issuing materially false and/or misleading information and/or failing to disclose material information.

    If you suffered a loss in Esperion Therapeutics, Inc. you have until July 6, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.